Gilead Sciences, Inc.GILDNASDAQ
LOADING
|||
Company Overview
: GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
Key Statistics
Market Cap
$150.25B
Price
$121.10
Volume
6.58M
Employees
17.00K
IPO Date
N/A
Currency
USD
Industry Classification
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Company Information
Chief Executive Officer
Daniel O'Day
Headquarters
333 Lakeside Dr, Foster City, California 94404-1147
Country
US
Phone
16505743000